PHF6 and cancer: This binding is highly conserved in the nucleoplasm, and thus mutations in PHF6 have been studied extensively in the field of cancer, especially leukemia; however, the effects of RBBP4 in mutated PHF6 are still less studied (Todd and Picketts, 2012; Liu et al., 2015).